Systematized epidermal nevus

From WikiMD's WELLNESSPEDIA


Systematized epidermal nevus
Synonyms
Pronounce N/A
Specialty Dermatology
Symptoms Hyperkeratosis, papillomatous lesions
Complications N/A
Onset Birth or early childhood
Duration Lifelong
Types N/A
Causes Genetic mutation
Risks
Diagnosis Clinical examination, biopsy
Differential diagnosis Linear epidermal nevus, nevus sebaceous, inflammatory linear verrucous epidermal nevus
Prevention N/A
Treatment Topical treatments, laser therapy, surgical excision
Medication N/A
Prognosis N/A
Frequency Rare
Deaths N/A


Systematized epidermal nevus is a type of epidermal nevus that is characterized by the presence of multiple, widespread lesions that follow the lines of Blaschko. These lesions are typically present at birth or develop in early childhood and can vary in size, shape, and color.

Clinical Presentation[edit]

Systematized epidermal nevi are often linear or whorled in appearance and can be found on any part of the body. They are usually hyperpigmented and may be raised or flat. The lesions can be isolated or part of a syndrome, such as epidermal nevus syndrome.

Pathophysiology[edit]

The condition is caused by a postzygotic mutation in the keratinocytes, leading to a mosaic pattern of skin involvement. The specific genetic mutations can vary, but they often involve genes related to the Ras/MAPK pathway, which is important in cell growth and differentiation.

Diagnosis[edit]

Diagnosis is primarily clinical, based on the characteristic appearance of the lesions. A skin biopsy may be performed to confirm the diagnosis and rule out other conditions. Histologically, the lesions show hyperkeratosis, acanthosis, and papillomatosis.

Treatment[edit]

Treatment options for systematized epidermal nevus are limited and primarily focus on cosmetic improvement. Options include:

Prognosis[edit]

The prognosis for individuals with systematized epidermal nevus is generally good, although the lesions are often persistent and may require ongoing management. In some cases, there may be an association with other systemic abnormalities, necessitating a multidisciplinary approach to care.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.